EGFR and adenocarcinoma: After waiting for confirmation of positive results by cytology and histology, which were obtained 3–4 days after bronchoscopic examination, the patient was diagnosed as having adenocarcinoma with an EGFR mutation (cT2aN0M1b, stage IV).